Leishmania (L.) amazonensis LaLRR17 increases parasite entry in macrophage by a mechanism dependent on GRP78

Mauricio S Peña1, Fenny Hui Fen Tang2, Fernando Alves de Lima Franco1

  • 1Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.

Parasitology
|August 8, 2023
PubMed

Insights

Leishmania parasites use a leucine-rich repeat protein (LaLRR17) to enhance macrophage infection. Blocking this protein interaction with macrophage GRP78 reduces parasite infectivity, offering a potential therapeutic target.

Area of Science:

  • Parasitology
  • Molecular Biology
  • Immunology

Background:

  • Leishmaniases are widespread protozoan parasitic diseases.
  • Leishmania parasites evade host macrophage defenses.
  • Leucine-rich repeat (LRR) proteins mediate protein-protein interactions.

Purpose of the Study:

  • To identify and characterize novel Leishmania virulence factors.
  • To investigate the role of LRR17 in Leishmania pathogenesis.
  • To explore the interaction between Leishmania and host macrophage molecules.

Main Methods:

  • Gene identification and overexpression in Leishmania (L.) amazonensis.
  • Recombinant protein production and purification.
  • Affinity chromatography and mass spectrometry for ligand identification.
  • In vitro infection assays to assess parasite infectivity.

Main Results:

  • The LRR17 gene was identified in Leishmania species.
  • Overexpression of LaLRR17 increased Leishmania promastigote infectivity in vitro.
  • Macrophage GRP78 was identified as a ligand for LaLRR17.
  • Blocking the LaLRR17-GRP78 interaction reduced parasite infectivity.

Conclusions:

  • Leishmania LRR17 is a novel virulence factor.
  • LaLRR17 facilitates Leishmania entry into macrophages by interacting with GRP78.
  • Targeting the LaLRR17-GRP78 interaction may offer a strategy for leishmaniasis treatment.

Related Concept Videos

Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...